Trial Profile
A study to assess the pharmacokinetics of dapivirine (TMC120) vaginal microbicide gel in healthy HIV-negative women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jul 2009
Price :
$35
*
At a glance
- Drugs Dapivirine (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- 14 Oct 2006 New trial record.